Alexion Pharmaceuticals - Company & Market Research Reports

Home /
Companies /
Alexion Pharmaceuticals

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 49
Central Nervous System Drugs 38
Immune Disorders Drugs 24
Biopharmaceuticals 22
Endocrine and Metabolic Disorders Drugs 21
Biotechnology 19
Hematological Drugs 19
Oncology Drugs 13
Pharmaceuticals 13
Liver and Kidney Disorders Drugs 12
Allergy and Immunology 10
Genomics 10
Musculoskeletal Disorders Drugs 10
Cardiovascular Drugs 9
Drugs by Therapeutic Area 8
Enzymes 8
Optical Disorders Drugs 6
Infusions and Injectables 6
Company Reports 5
Drug Delivery 5
Hematology 5
Therapeutic Area 4
Clinical Trials 4
Diagnostics 4
Needles and Syringes 4
Infectious Diseases Drugs 3
Proteomics 3
Laboratory Equipment 3
Pharmaceutical Manufacturing 3
Pharmaceutical Intermediates 2
In Vitro Diagnostics 2
Optical 2
Vaccines 2
Respiratory Drugs 2
Biosimilars and Biosuperiors 2
Dermatological Drugs 2
Allergy Drugs 2
Addiction Disorders Drugs 1
Urology and Nephrology 1
Pharmacoeconomics 1
Leukemia Drugs 1
Lymphoma Drugs 1
Colon Cancer Drugs 1
Bioinformatics 1
Cardiovascular Devices 1
Stents 1
Infectious Disease Testing 1
Analgesics 1
Cough and Cold Drugs 1
Diabetes Devices 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Medical Devices 1
Biomarkers 1
Gastrointestinal Drugs 1
Nanomedicine 1
Gastroenterology 1
Oncology 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

271 Results (Page 5 of 14)
- Relevance
  Sort by

LAMEA Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030

 Report
November 2023
116 Pages
Middle East, Africa

From

€1466EUR$1,500USD£1,224GBP

North America Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030

 Report
November 2023
107 Pages
North America

From

€1466EUR$1,500USD£1,224GBP

Complement C5 inhibitors - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1026EUR$1,050USD£856GBP

€1466EUR$1,500USD£1,224GBP

Enzyme Replacement Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Enzyme Type, Therapeutic Conditions, Route of Administration, and End User

 Report
July 2022
226 Pages
Global

From

€3112EUR$3,185USD£2,598GBP

€4446EUR$4,550USD£3,711GBP

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

 Report
January 2019
230 Pages
Global

From

€3907EUR$3,999USD£3,262GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Transthyretin Amyloidosis Treatment Market Report and Forecast 2023-2031

 Report
March 2023
147 Pages
Global

From

€5861EUR$5,999USD£4,893GBP

Blood Disorder Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
January 2022
115 Pages
Global

From

€4641EUR$4,750USD£3,874GBP

Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
289 Pages
Global

From

€2443EUR$2,500USD£2,039GBP

Age-related Macular Degeneration (AMD) - Market Insight, Epidemiology And Market Forecast - 2032

 Report
June 2022
320 Pages
Global

From

€9507EUR$9,730USD£7,936GBP

€13581EUR$13,900USD£11,338GBP

Bioinformatics Collaboration and Licensing Deals 2019-2024

 Report
November 2024
450 Pages
Global

From

€3903EUR$3,995USD£3,259GBP

Biotechnology Services Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€3908EUR$4,000USD£3,263GBP

Biotech Ingredient Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4885EUR$5,000USD£4,078GBP

Smart Life Sciences Manufacturing Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€3908EUR$4,000USD£3,263GBP

mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035: Distribution by Application Area, Target Disease Indication and Geographical Regions

 Report
September 2024
343 Pages
Global

From

€4689EUR$4,799USD£3,914GBP

Global Proteomics Partnering Terms and Agreements 2010 to 2023

 Report
June 2023
400 Pages
Global

From

€3903EUR$3,995USD£3,259GBP

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
1814 Pages
Global

From

€1954EUR$2,000USD£1,631GBP

Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

 Report
December 2023
492 Pages
Global

From

€3908EUR$4,000USD£3,263GBP

Proteomics: Technologies and Global Markets

 Report
December 2022
384 Pages
Global

From

€5374EUR$5,500USD£4,486GBP

B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
139 Pages
Global

From

€1954EUR$2,000USD£1,631GBP

Neurofibromatoses Type I (Von Recklinghausen's Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
72 Pages
Global

From

€1954EUR$2,000USD£1,631GBP

271 Results (Page 5 of 14)
- 1
- 3
- 4
- 5
- 6
- 7

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.